(Total Views: 580)
Posted On: 04/05/2021 12:06:20 PM
Post# of 155764
More anecdotal evidence as to the effectiveness of Leronlimab in treating Covid that the US FDA will likely ignore.
The big question for investors is whether the Philippines FDA, and other global FDA's, will issue EUA's given that there is little risk in doing so as Leronlimab has not resulted in any serious adverse events in the treatment of over 1,000 patients for Covid, cancer, and HIV.
The big question for investors is whether the Philippines FDA, and other global FDA's, will issue EUA's given that there is little risk in doing so as Leronlimab has not resulted in any serious adverse events in the treatment of over 1,000 patients for Covid, cancer, and HIV.
(3)
(0)
The Lawman
style="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]
